{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:10:30Z","timestamp":1789506630995,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005104","name":"Australian Institute of Health and Welfare, Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005104","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.vaccine.2026.128922","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T09:27:47Z","timestamp":1784021267000},"page":"128922","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The cost of respiratory syncytial virus (RSV) across all ages to the Australian healthcare system"],"prefix":"10.1016","volume":"88","author":[{"given":"Kishor K.","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony T.","family":"Newall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128922_bb0005","author":"World Health Organization."},{"issue":"10","key":"10.1016\/j.vaccine.2026.128922_bb0010","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01432-25","article-title":"High seroprevalence and high risk: why are older adults more prone to respiratory syncytial virus?","volume":"99","author":"Rzymski","year":"2025","journal-title":"J Virol"},{"issue":"10340","key":"10.1016\/j.vaccine.2026.128922_bb0015","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"issue":"Suppl. 7","key":"10.1016\/j.vaccine.2026.128922_bb0020","doi-asserted-by":"crossref","first-page":"S577","DOI":"10.1093\/infdis\/jiz059","article-title":"Global disease burden estimates of respiratory syncytial virus\u2013associated acute respiratory infection in older adults in 2015: a systematic review and meta-analysis","volume":"222","author":"Shi","year":"2020","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128922_bb0025","doi-asserted-by":"crossref","first-page":"447","DOI":"10.5694\/mja2.50159","article-title":"Respiratory syncytial virus-associated hospitalisations in Australia, 2006\u20132015","volume":"210","author":"Saravanos","year":"2019","journal-title":"Med J Aust"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128922_bb0030","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/irv.13003","article-title":"Modelled estimates of hospitalisations attributable to respiratory syncytial virus and influenza in Australia, 2009\u20132017","volume":"16","author":"Nazareno","year":"2022","journal-title":"Influenza Other Respi Viruses"},{"key":"10.1016\/j.vaccine.2026.128922_bb0035","author":"Australian Government Department of Health, Disability and Ageing."},{"issue":"2","key":"10.1016\/j.vaccine.2026.128922_bb0040","doi-asserted-by":"crossref","first-page":"177","DOI":"10.33321\/cdi.2011.35.15","article-title":"Respiratory syncytial virus - the unrecognised cause of health and economic burden among young children in Australia","volume":"35","author":"Ranmuthugala","year":"2011","journal-title":"Commun Dis Intell Q Rep"},{"key":"10.1016\/j.vaccine.2026.128922_bb0045","doi-asserted-by":"crossref","DOI":"10.33321\/cdi.2022.46.5","article-title":"The 2018 annual cost burden for children under five years of age hospitalised with respiratory syncytial virus in Australia","volume":"46","author":"Brusco","year":"2022","journal-title":"Commun Dis Intell."},{"key":"10.1016\/j.vaccine.2026.128922_bb0050","author":"Australian Government Department of Health, Disability and Ageing."},{"key":"10.1016\/j.vaccine.2026.128922_bb0055","author":"Australian Bureau of Statistics."},{"issue":"6 February 2025","key":"10.1016\/j.vaccine.2026.128922_bb0060","article-title":"Estimating the cost-effectiveness of maternal respiratory syncytial virus (RSV) vaccination in Australia: a dynamic and economic modelling analysis","volume":"46","author":"Nazareno","year":"2025","journal-title":"Vaccine"},{"issue":"26","key":"10.1016\/j.vaccine.2026.128922_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126418","article-title":"Modelling the epidemiological impact of maternal respiratory syncytial virus (RSV) vaccination in Australia","volume":"42","author":"Nazareno","year":"2024","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128922_bb0070","doi-asserted-by":"crossref","first-page":"2002688","DOI":"10.1183\/13993003.02688-2020","article-title":"Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort study","volume":"57","author":"Korsten","year":"2021","journal-title":"Eur Respir J"},{"issue":"17","key":"10.1016\/j.vaccine.2026.128922_bb0075","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa043951","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults","volume":"352","author":"Falsey","year":"2005","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128922_bb0080","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1093\/infdis\/jiv263","article-title":"Frequent asymptomatic respiratory syncytial virus infections during an epidemic in a rural Kenyan household cohort","volume":"212","author":"Munywoki","year":"2015","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128922_bb0085","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1007\/s00431-021-03998-0","article-title":"Epidemiology of respiratory syncytial virus in a community birth cohort of infants in the first 2 years of life","volume":"180","author":"Takashima","year":"2021","journal-title":"Eur J Pediatr"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128922_bb0090","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/irv.12686","article-title":"Estimates for quality of life loss due to respiratory syncytial virus","volume":"14","author":"Hodgson","year":"2020","journal-title":"Influenza Other Respi Viruses"},{"key":"10.1016\/j.vaccine.2026.128922_bb0100","author":"New South Wales Health."},{"key":"10.1016\/j.vaccine.2026.128922_bb0105","author":"Australian Institute of Health and Welfare."},{"key":"10.1016\/j.vaccine.2026.128922_bb0110","author":"Reserve Bank of Australia."},{"key":"10.1016\/j.vaccine.2026.128922_bb0115","author":"Australian Government Department of Health, Disability and Ageing."},{"key":"10.1016\/j.vaccine.2026.128922_bb0120","author":"Australian Institute of Health and Welfare."},{"key":"10.1016\/j.vaccine.2026.128922_bb0125","author":"Independent Health and Aged Care Pricing Authority."},{"key":"10.1016\/j.vaccine.2026.128922_bb0130","author":"Independent Hospital Pricing Authority."},{"issue":"1","key":"10.1016\/j.vaccine.2026.128922_bb0135","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pathol.2025.06.011","article-title":"Epidemiology of respiratory syncytial virus within a New South Wales-based multi-centre health district between 2018 and 2024 in Australia","volume":"58","author":"Akhtar","year":"2026","journal-title":"Pathology"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128922_bb0140","doi-asserted-by":"crossref","DOI":"10.1111\/irv.70092","article-title":"Estimated incidence of hospitalisations and deaths attributable to respiratory syncytial virus infections in adults in Australia between 2010 and 2019","volume":"19","author":"Wiid","year":"2025","journal-title":"Influenza Other Respi Viruses"}],"updated-by":[{"DOI":"10.1016\/j.vaccine.2026.129019","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000}},{"DOI":"10.1016\/j.vaccine.2026.129019","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:00:00Z","timestamp":1788048000000}}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26007310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26007310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:33:08Z","timestamp":1789504388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26007310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":27,"alternative-id":["S0264410X26007310"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128922","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The cost of respiratory syncytial virus (RSV) across all ages to the Australian healthcare system","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128922","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128922"}}